📚 PASS Investment Adviser (Level 2) Difficulty: Beginner ℹ️ Info   ~5 min read
📌 Chapter 2.3 — Types of Life Insurance Products

Imagine you are reviewing a client’s comprehensive insurance portfolio during an annual wealth audit. You notice that their term life plan includes an accelerated critical illness (CI) rider with a sum assured of ₹50 lakh. While the client feels secure, a deeper look at their potential liabilities reveals a critical oversight in how this payout interacts with their death benefit. As an analyst, you must determine whether this structure offers sufficient liquidity or if it inadvertently strips the family of future protection when they might need it most.

An ‘accelerated’ rider functions by prepaying a portion of the base death benefit upon the diagnosis of a listed critical illness. This is efficient for immediate cash-flow requirements like medical expenses or debt repayment, but it reduces the life insurance payout available to beneficiaries upon the insured’s eventual death. Conversely, a standalone rider exists as a separate contract or add-on that pays out independently of the base policy.

In this case, the full life insurance sum remains intact, providing two distinct pools of capital for two distinct risks: living costs during recovery and long-term legacy protection.

When evaluating these options, consider the ‘opportunity cost of coverage.’ If a client opts for an accelerated rider, they are essentially ‘buying’ early liquidity by cannibalizing their own long-term death benefit. This makes sense for individuals with high current debt who need to offset major liabilities immediately. However, for a client focused on estate planning or providing for long-term dependents, a standalone rider is usually superior. It ensures that a major illness does not erode the financial safety net designed for the surviving family members.

From a model-building perspective, the professional recommendation hinges on the client’s ‘Human Life Value’ (HLV) calculation. If the client’s total insurance stack is barely sufficient to cover their current liabilities, an accelerated rider introduces a hidden risk where the family may be left under-insured following an illness-related payout. Always conduct a dual-scenario analysis: one where the client passes away without a prior diagnosis, and one where they suffer a critical illness, recover, and subsequently die years later.

This helps ensure that the chosen rider structure maintains the required coverage adequacy across all life events.1

Nuance

⚠️ Nuance
The most common pitfall for candidates is the assumption that ‘more is better’ without regard for the interplay between policy limits. Students often mistake the total payout capacity for the available death benefit, forgetting that the accelerated rider is an advance payment rather than an additive one. An effective analyst must always scrutinize the policy document to check for ‘sum assured depletion’ clauses, as failure to do so can lead to a significant recommendation error in a financial plan.

Check Your Understanding

Practice Question 1

A client has a base term life policy of ₹1 crore and an attached Accelerated Critical Illness (CI) rider of ₹20 lakh. If the client is diagnosed with a covered critical illness and receives the ₹20 lakh payout, what is the remaining death benefit payable to their beneficiaries upon the client’s death?

Practice Question 2

Which of the following scenarios best justifies the recommendation of a ‘Standalone’ Critical Illness rider over an ‘Accelerated’ one?

This is a companion read for Section 2.3 — Types of Life Insurance Products from PASS Investment Adviser (Level 2) by Akhilesh Gururani, available on Amazon Kindle.

Copyright © 2026 Akhilesh Gururani. All rights reserved.

  1. The Human Life Value (HLV) is the present value of an individual’s future earnings minus their personal consumption, serving as a baseline for determining appropriate life insurance coverage. ↩︎